Sign up
Pharma Capital

WideCells Group CEO Joao Andrade 'very pleased' with investor response to £649k raise

Joao Andrade, chief executive of WideCells Group PLC (LON:WDC) tells Proactive the stem cell storage specialist has raised £649,000 through a private placing to speed up development of its three main divisions, CellPlan, WideCells and WideAcademy.

 

View full WDC profile

WideCells Group Timeline

Newswire

WideCells expands its reach to Spain

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.